Literature DB >> 23073128

Gemcitabine associated with posterior reversible encephalopathy syndrome (PRES): a case report and review of the literature.

Quoc Van Truong1, Jame Abraham, Govardhanan Nagaiah, Mike Newton, Lauren Veltri.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23073128

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  4 in total

Review 1.  Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.

Authors:  Joan How; Margaret Blattner; Susan Fowler; Andrea Wang-Gillam; Suzanne E Schindler
Journal:  Neurologist       Date:  2016-11       Impact factor: 1.398

2.  Neurological variability in chemotherapy-induced posterior reversible encephalopathy syndrome associated with thrombotic microangiopathy: Case reports and literature review.

Authors:  Chen Makranz; Salome Khutsurauli; Yosef Kalish; Ruth Eliahou; Luna Kadouri; John Moshe Gomori; Alexander Lossos
Journal:  Mol Clin Oncol       Date:  2017-11-02

3.  Posterior reversible encephalopathy syndrome (PRES) associated with ovarian cancer and voltage-gated potassium channel antibodies: A case report.

Authors:  Laura K Hadad; Caroline C Billingsley
Journal:  Gynecol Oncol Rep       Date:  2017-03-08

4.  A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin.

Authors:  Hannah Cherniawsky; Neesha Merchant; Micheal Sawyer; Maria Ho
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.